Short description
CELLPROTEK is a small molecule drug development company.
Description
CELLPROTEK provides small molecule drugs for the treatment of major diseases of the central nervous system. They also create medications for acute ischemia stroke, alzheimer's disease, cardiovascular, cerebrovascular, and neurodegenerative diseases.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Guangzhou, Guangdong, China, Asia
Founded on
April 26, 2011
Exited on
January 6, 2016
Went public on
January 6, 2016
Stock symbol
835346
Non-profit?
No
Acquired?
No
Employees count
11-50